http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_64963bf877897f360d86205798699b08
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Clapham |
| name | Paul R. Clapham Paul R Clapham |
| given-name | Paul R Paul R. |
| organization-name | University of Massachusetts, Medical School Worcester Massachusetts Program in Molecular Medicine and Department of Molecular Genetics and Microbiology, University of Massachusetts, Worcester, Massachusetts Center for AIDS Research, Program in Molecular Medicine, and Department of Molecular Genetics and Microbiology, 373 Plantation Street, University of Massachusetts Medical School, Worcester, Massachusetts 01605 Center for AIDS Research, Program in Molecular Medicine and Department of Molecular Genetics and Microbiology, 373 Plantation Street, University of Massachusetts Medical School, Worcester, Massachusetts 01605 Chester Beatty Laboratories, Institute of Cancer Research, London SW3 6JB, United Kingdom Chester Beatty Laboratories, Institute of Cancer Research, London SW3 6JB, U.K. Section of Virology, Chester Beatty Laboratories, Institute of Cancer Research, London SW3 6JB,1 and Program in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation Street, Worcester, MA 01605, USA Program in Molecular Medicine and Department of Molecular Genetics and Microbiology, Biotech 2, 373 Plantation Street, University of Massachusetts Medical School, Worcester, Massachusetts 01605 The Wohl Virion Centre, Department of Immunology and Molecular Pathology, The Windeyer Institute of Medical Sciences, University College London, 46 Cleveland Street, London W1P 6DB, UK1 Section of Virology, Chester Beatty Laboratories, Institute of Cancer Research, London SW3 6JB, United Kingdom From the *Medizinische Poliklinik, Ludwig-Maximilians-University of Munich, 80336 Munich, Germany; the ‡Institute for Animal Physiology, University of Munich, 80539 Munich, Germany; the §Section of Virology, Chester Beatty Laboratories, Institute of Cancer Research, London SW3 6JB, United Kingdom; the ‖Medical Research Council Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, United Kingdom; and the ¶Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development SA, 1228 Plan-les-Ouates, Geneva, Switzerland Suite 315, Biotech 2, Program in Molecular Medicine, University of Massachusetts Medical School, 373 Plantation Street, Worcester, MA 01605, USA Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA Center for AIDS Research, Program in Molecular Medicine, Department of Molecular Genetics and Microbiology, University of Massachusetts Medical School, Biotech II, 373, Plantation Street, Worcester. MA 01605, USA1 The Wohl Virion Centre, Department of Molecular Pathology, Windeyer Institute of Medical Sciences, University College London, London, United Kingdom,1 and The Wohl Virion Centre, Department of Molecular Pathology, The Windeyer Institute for Medical Sciences, University College Medical School , London, UK Center for AIDS Research, Program in Molecular Medicine, Department of Molecular Genetics and Microbiology, University of Massachusetts Medical School, Worcester, Massachusetts 01605 Chester Beatty Laboratories, Institute of Cancer Research Program in Molecular Medicine and Department of Molecular Genetics and Microbiology, University of Massachusetts Medical School, Worcester, Massachusetts 01605 T. N. Kledal, M. M. Rosenkilde, T. W. Schwartz, Laboratory for Molecular Pharmacology, Institute of Pharmacology, Panum Institute, University of Copenhagen, DK-2200 Copenhagen, Denmark.; A. H. Johnsen, Department of Clinical Biochemistry; H. R. Lüttichau and J. Gerstoft, Department of Infectious Diseases, Rigshospitalet, DK-2100 Copenhagen, Denmark.; G. Simmons and P. R. Clapham, Section of Virology, Chester Beatty Laboratories, The Institute of Cancer Research, Fulham Road, London, SW3 6JB, UK.; I. Clark-Lewis, Biomedical Research Center, University of British Columbia, Vancouver, B.C., V6T 1Z3, Canada.; F. Coulin, S. Alouani, C. A. Power, T. N. C. Wells, Geneva Biomedical Research Institute, Glaxo Wellcome Research and Development S.A., 1228 Plan-les-Ouates, Geneva, Switzerland. Program in Molecular Medicine and Department of Microbiology and Physiological Systems, University of Massachusetts Medical School, Worcester, Massachusetts, USA Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA G. Simmons, P. R. Clapham, L. Picard, Virology Group, Chester Beatty Laboratories, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK.; R. E. Offord, Départment de Biochimie Médicale, Centre Médical Universitaire, 9 Avenue de Champel, 1211 Geneva 4, Switzerland, and Gryphon Sciences, 250 East Grand Avenue, Suite 90, South San Francisco, CA 94080, USA.; M. M. Rosenkilde and T. W. Schwartz, Laboratory for Molecular Pharmacology, Rigshospitalet 6321, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.; R. Buser, T. N. C. Wells, A. E. I. Proudfoot, Geneva Biomedical Research Institute, GlaxoWellcome Research and Development SA, 14 chemin des Aulx, 1228 Plan-les-Ouates, Geneva, Switzerland. Section of Virology, Chester Beatty Laboratories, Institute of Cancer Research,1 and Program in Molecular Medicine, University of Massachusetts Medical School, Biotech 2, Worcester, Massachusetts, USA Program in Molecular Medicine, Center for AIDS Research; Department of Molecular Genetics and Microbiology, Two Biotech, University of Massachusetts Medical School, 373 Plantation Street, Worcester, Massachusetts 01605 Program in Molecular Medicine, University of Massachusetts, Worcester, Massachusetts Department of Molecular Genetics and Microbiology, University of Massachusetts Medical School, Worcester, MA 01605, USA |
Incoming Links
Total number of triples: 118.